Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL

Catalog number BNC402699-500

Price for BNC402699-500

Size / count 1x 500 µL

About this product

Laminins, a family of extracellular matrix glycoproteins, are the major non-collagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Many of the effects of laminin are mediated through interactions with cell surface receptors. These receptors include members of the integrin family, as well as non-integrin laminin-binding proteins. This gene encodes a high-affinity, non-integrin family, laminin receptor 1. Reportedly, level of laminin receptor transcript is higher in colon carcinoma tissue and lung cancer cell line than their normal counterparts. Also, there is a correlation between the upregulation of this polypeptide in cancer cells and their invasive and metastatic phenotype. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC402699-500
Size / count: 1x 500 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: 34/67kDa Laminin Receptor; 37kDa Laminin Receptor precursor; 37/67kDa Laminin Receptor; 37LRP; 40S Ribosomal Protein SA; 67kDa Laminin Receptor; 67LR; Colon Carcinoma Laminin-binding Protein; LAMBR; Laminin receptor 1; Laminin-binding Protein precursor p40; LAMR1; LBP/p40; LRP/LR; Multidrug resistance-associated protein MGr1-Ag; NEM/1CHD4; Ribosomal Protein SA (RPSA)
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: RPSA
Gene ID: 3921
NCBI Gene ID: 449909
UniProt: P08865
Swiss Prot: P08865
Host: Mouse
Species Reactivity: Human
Reactivity: Laminin Receptor|RPSA
Immunogen: Recombinant full-length human RPSA protein
Target Antigen: Laminin Receptor | RPSA
Clonality: Monoclonal
Clone: RPSA/2699
Type: Primary
Source: Animal
Origin: Animal
Applications: Flow (verified) |IF (verified)
Positive Control: MCF-7, MDA-MB-453, SK-BR3, THP1, HL60, HeLa or HEK293 cells. Breast, Colon or Ovarian Carcinoma, Tonsil.
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 37-67 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF640R

Frequently Asked Questions

What is the catalog number for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL?

The catalog number for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL is BNC402699-500.

What sizes are available for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL?

Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.

Is Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL in stock?

Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL?

Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL?

Estimated delivery time for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL?

The safety data sheet for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029a061270361e1016dd/msds/bnc402699-500.pdf.

What is Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), CF640R conjugate, 0.1mg/mL used for?

What is the molecular weight of the target protein?

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

How long will it take to receive this product if it’s custom made?

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

What is the recommended dilution for this antibody?

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.